Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jingyin Mixture
- Development stage
- Unknown
- Lead developer
- Shuguang Hospital
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Jingyin Mixture is a Traditional Chinese Medicine (TCM) hospital preparation developed by Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine. It is an oral liquid formulation primarily used for the treatment of viral respiratory diseases, including COVID-19. The mixture is composed of several herbal ingredients, notably Schizonepeta tenuifolia (Jingjie) and Lonicera japonica (Jinyinhua), which are traditionally used to clear heat, resolve the exterior, and detoxify. During the COVID-19 pandemic, it was widely deployed in Shanghai as part of the standard TCM protocol for mild and moderate cases to prevent progression to severe disease. Clinical evaluation has focused on its ability to shorten viral shedding time and improve clinical symptoms such as fever and cough.
- Brand names
- Jingyin Mixture
- Other names
- Jingyin HejiJingyin Formula
02
Targets
CYP2C19 (Cytochrome P450 2C19)CYP1A2 (Cytochrome P450 1A2)CYP3A4 (Cytochrome P450 3A4)CYP2C9 (Cytochrome P450 family 2 subfamily C member 9)
Beyond the preview
Go deeper on Jingyin Mixture.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jingyin Mixture.